274 related articles for article (PubMed ID: 25840980)
1. Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?
Fan Z; Harold D; Pasqualetti G; Williams J; Brooks DJ; Edison P
J Nucl Med; 2015 May; 56(5):707-13. PubMed ID: 25840980
[TBL] [Abstract][Full Text] [Related]
2. Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding.
Guo Q; Colasanti A; Owen DR; Onega M; Kamalakaran A; Bennacef I; Matthews PM; Rabiner EA; Turkheimer FE; Gunn RN
J Nucl Med; 2013 Nov; 54(11):1915-23. PubMed ID: 24071511
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
[TBL] [Abstract][Full Text] [Related]
4. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.
Kreisl WC; Lyoo CH; McGwier M; Snow J; Jenko KJ; Kimura N; Corona W; Morse CL; Zoghbi SS; Pike VW; McMahon FJ; Turner RS; Innis RB;
Brain; 2013 Jul; 136(Pt 7):2228-38. PubMed ID: 23775979
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis.
Bradburn S; Murgatroyd C; Ray N
Ageing Res Rev; 2019 Mar; 50():1-8. PubMed ID: 30610927
[TBL] [Abstract][Full Text] [Related]
6. Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.
Suridjan I; Rusjan PM; Kenk M; Verhoeff NP; Voineskos AN; Rotenberg D; Wilson AA; Meyer JH; Houle S; Mizrahi R
Synapse; 2014 Nov; 68(11):536-47. PubMed ID: 25043159
[TBL] [Abstract][Full Text] [Related]
7. [
Kim K; Kim H; Bae SH; Lee SY; Kim YH; Na J; Lee CH; Lee MS; Ko GB; Kim KY; Lee SH; Song IH; Cheon GJ; Kang KW; Kim SE; Chung JK; Kim EE; Paek SH; Lee JS; Lee BC; Youn H
Theranostics; 2020; 10(20):9315-9331. PubMed ID: 32802194
[TBL] [Abstract][Full Text] [Related]
8. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein.
Lyoo CH; Ikawa M; Liow JS; Zoghbi SS; Morse CL; Pike VW; Fujita M; Innis RB; Kreisl WC
J Nucl Med; 2015 May; 56(5):701-6. PubMed ID: 25766898
[TBL] [Abstract][Full Text] [Related]
9. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects.
Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766
[TBL] [Abstract][Full Text] [Related]
11. Integrating TSPO PET imaging and transcriptomics to unveil the role of neuroinflammation and amyloid-β deposition in Alzheimer's disease.
Zhang M; Qian XH; Hu J; Zhang Y; Lin X; Hai W; Shi K; Jiang X; Li Y; Tang HD; Li B
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):455-467. PubMed ID: 37801139
[TBL] [Abstract][Full Text] [Related]
12. Translocator Protein (18 kDa) Polymorphism (rs6971) in the Korean Population.
Lee H; Noh Y; Kim WR; Seo HE; Park HM
Dement Neurocogn Disord; 2022 Apr; 21(2):71-78. PubMed ID: 35585910
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of (S)-[
Ramakrishnan NK; Hird M; Thompson S; Williamson DJ; Qiao L; Owen DR; Brooks AF; Scott PJH; Bacallado S; O'Brien JT; Aigbirhio FI
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):125-136. PubMed ID: 34405276
[TBL] [Abstract][Full Text] [Related]
14. Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.
Landau SM; Horng A; Fero A; Jagust WJ;
Neurology; 2016 Apr; 86(15):1377-1385. PubMed ID: 26968515
[TBL] [Abstract][Full Text] [Related]
15. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging.
Hamelin L; Lagarde J; Dorothée G; Leroy C; Labit M; Comley RA; de Souza LC; Corne H; Dauphinot L; Bertoux M; Dubois B; Gervais P; Colliot O; Potier MC; Bottlaender M; Sarazin M;
Brain; 2016 Apr; 139(Pt 4):1252-64. PubMed ID: 26984188
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains.
Gui Y; Marks JD; Das S; Hyman BT; Serrano-Pozo A
Brain Pathol; 2020 Jan; 30(1):151-164. PubMed ID: 31276244
[TBL] [Abstract][Full Text] [Related]
18. Identifying improved TSPO PET imaging probes through biomathematics: the impact of multiple TSPO binding sites in vivo.
Guo Q; Owen DR; Rabiner EA; Turkheimer FE; Gunn RN
Neuroimage; 2012 Apr; 60(2):902-10. PubMed ID: 22251896
[TBL] [Abstract][Full Text] [Related]
19. Imaging characteristics and safety of florbetapir (¹⁸F) in Japanese healthy volunteers, patients with mild cognitive impairment and patients with Alzheimer's disease.
Namiki C; Takita Y; Iwata A; Momose T; Senda M; Okubo Y; Joshi AD; Lu M; Agbulos A; Breault C; Pontecorvo MJ
Ann Nucl Med; 2015 Aug; 29(7):570-81. PubMed ID: 25943346
[TBL] [Abstract][Full Text] [Related]
20. Predictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [Corrected].
Ma Y; Zhang S; Li J; Zheng DM; Guo Y; Feng J; Ren WD
Medicine (Baltimore); 2014 Dec; 93(27):e150. PubMed ID: 25501055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
